Product Information
ROPINIROLE HCL 5 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0766 per EA under NDC 62332003631. Its NADAC has been published 529 times since May 11, 2016.
Strength
5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332003631
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090429On Market Since
1/29/2016
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 5 MG TABLET has been published 529 times since May 11, 2016, and over the history we have for it it has declined 33.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0766 per EA |
|---|---|
| All-time high | $0.1401 (Dec 11, 2019) |
| All-time low | $0.0672 (Jan 22, 2025) |
| 52-week high | $0.0890 |
| 52-week low | $0.0748 |
| Median price | $0.1060 |
| Average price | $0.1047 |
| Largest weekly change | +51.8% (Dec 20, 2023) |
| Weeks tracked | 529 |
| Tracking since | May 11, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ROPINIROLE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 5 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.0766 per EA (NDC 62332003631), effective Jun 24, 2026.
How has the price of ROPINIROLE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 5 MG TABLET has declined 33.1%. It has been tracked across 529 weekly CMS publications since May 11, 2016.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 5 MG TABLET?
Since May 11, 2016, the NADAC for ROPINIROLE HCL 5 MG TABLET has ranged from a low of $0.0672 (Jan 22, 2025) to a high of $0.1401 (Dec 11, 2019), with a median of $0.1060 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ROPINIROLE HCL 5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ROPINIROLE HCL 5 MG TABLET?
ROPINIROLE HCL 5 MG TABLET (NDC 62332003631) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification